Influenza Vaccine in Pediatric Transplant Subjects
Influenza
About this trial
This is an interventional prevention trial for Influenza focused on measuring children, immunocompromised, influenza, liver transplant
Eligibility Criteria
Inclusion Criteria: Informed consent from parent/guardian and assent from participants, when applicable, must have been obtained and signed freely. Between the ages of 6 months and 17 years. Three months have elapsed since liver transplantation. Recipient of a liver transplant or live with a sibling who is the recipient of a liver transplant. Must have the ability to comply with the study procedures for the entire length of the study. Exclusion Criteria: Previous immunization with an influenza vaccine for the 2004-2005 or 2005-2006 influenza season. Known hypersensitivity reaction to the vaccine or vaccine component including eggs or gelatin. History of Guillian-Barré syndrome. Receipt of an immunoglobulin product (including intravenous or intramuscular immunoglobulin preparations, cytomegalovirus hyperimmunoglobulin and varicella-zoster immunoglobulin) within 3 months of vaccination. Receipt of any live viral vaccines within 4 weeks or an inactivated viral vaccine within 2 weeks of enrollment. Subjects who have experienced an acute febrile illness within the preceding 48 hours will have immunization deferred and be rescheduled once their fever has resolved.
Sites / Locations
- Mount Sinai Hospital